Alarm over risk of mixing up booster and conventional vaccine - Los Angeles Times
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
COVID-19 Vaccine Boosters | La Dept. of Health
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health